LRRK2 and Parkinson disease: Stokholm et al. has reported the elevation of microglia activation in the substantial nigra of individuals with high risk for development of PD, including REM sleep behavior disorders and non-manifesting carriers with LRRK2 G2019S mutation [30, 31].